
Sean M. Basquill
Examiner (ID: 6963, Phone: (571)270-5862 , Office: P/1613 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1612, 1614, 1613 |
| Total Applications | 1332 |
| Issued Applications | 496 |
| Pending Applications | 114 |
| Abandoned Applications | 739 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18197256
[patent_doc_number] => 20230050775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => HAIR COSMETIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/788266
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788266 | HAIR COSMETIC COMPOSITION | Nov 15, 2020 | Pending |
Array
(
[id] => 18656061
[patent_doc_number] => 20230301927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => PROCESS FOR PRODUCING AN ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION WITH COLONIC DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/776723
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776723 | PROCESS FOR PRODUCING AN ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION WITH COLONIC DELIVERY | Nov 12, 2020 | Pending |
Array
(
[id] => 16655982
[patent_doc_number] => 20210052618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => FORMULATION OF GLUCOSINOLATES AND MYROSINASE
[patent_app_type] => utility
[patent_app_number] => 17/093302
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17093302
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/093302 | FORMULATION OF GLUCOSINOLATES AND MYROSINASE | Nov 8, 2020 | Abandoned |
Array
(
[id] => 17733339
[patent_doc_number] => 20220218798
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2022-07-14
[patent_title] => COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
[patent_app_type] => utility
[patent_app_number] => 17/092184
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/092184 | COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS | Nov 5, 2020 | Abandoned |
Array
(
[id] => 17733339
[patent_doc_number] => 20220218798
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2022-07-14
[patent_title] => COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
[patent_app_type] => utility
[patent_app_number] => 17/092184
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/092184 | COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS | Nov 5, 2020 | Abandoned |
Array
(
[id] => 17020979
[patent_doc_number] => 20210244850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => INJECTABLE SILK FIBROIN PARTICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/091835
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/091835 | INJECTABLE SILK FIBROIN PARTICLES AND USES THEREOF | Nov 5, 2020 | Abandoned |
Array
(
[id] => 18034482
[patent_doc_number] => 20220378697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => SUPPOSITORY CAPSULE
[patent_app_type] => utility
[patent_app_number] => 17/772695
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772695 | SUPPOSITORY CAPSULE | Oct 29, 2020 | Pending |
Array
(
[id] => 17774911
[patent_doc_number] => 20220241260
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2022-08-04
[patent_title] => Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists
[patent_app_type] => utility
[patent_app_number] => 17/083386
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083386
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083386 | Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists | Oct 28, 2020 | Abandoned |
Array
(
[id] => 17774911
[patent_doc_number] => 20220241260
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2022-08-04
[patent_title] => Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists
[patent_app_type] => utility
[patent_app_number] => 17/083386
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083386
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083386 | Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists | Oct 28, 2020 | Abandoned |
Array
(
[id] => 17034933
[patent_doc_number] => 20210251891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => CHLOROGENIC ACID-CONTAINING COMPOSITION FOR NASAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/060593
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/060593 | Chlorogenic acid-containing composition for nasal administration | Sep 30, 2020 | Issued |
Array
(
[id] => 16792018
[patent_doc_number] => 20210121835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => NANO EMULSION PROCESS FOR SCENTED LIQUIDS
[patent_app_type] => utility
[patent_app_number] => 17/031841
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17031841
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/031841 | NANO EMULSION PROCESS FOR SCENTED LIQUIDS | Sep 23, 2020 | Abandoned |
Array
(
[id] => 16718472
[patent_doc_number] => 20210085619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => Nanoencapsulated Combination Drug Formulations
[patent_app_type] => utility
[patent_app_number] => 17/030286
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/030286 | Nanoencapsulated combination drug formulations | Sep 22, 2020 | Issued |
Array
(
[id] => 17648418
[patent_doc_number] => 11351117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Water soluble compositions and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 17/020729
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 41963
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/020729 | Water soluble compositions and methods of making the same | Sep 13, 2020 | Issued |
Array
(
[id] => 17648418
[patent_doc_number] => 11351117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Water soluble compositions and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 17/020729
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 41963
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/020729 | Water soluble compositions and methods of making the same | Sep 13, 2020 | Issued |
Array
(
[id] => 17648418
[patent_doc_number] => 11351117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Water soluble compositions and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 17/020729
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 41963
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/020729 | Water soluble compositions and methods of making the same | Sep 13, 2020 | Issued |
Array
(
[id] => 17648418
[patent_doc_number] => 11351117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Water soluble compositions and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 17/020729
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 41963
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/020729 | Water soluble compositions and methods of making the same | Sep 13, 2020 | Issued |
Array
(
[id] => 16930621
[patent_doc_number] => 20210196510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => IMPLANTABLE THERAPEUTIC DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/016953
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016953
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016953 | IMPLANTABLE THERAPEUTIC DEVICE | Sep 9, 2020 | Abandoned |
Array
(
[id] => 17618935
[patent_doc_number] => 11337961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Self-emulsifying formulations of DIM-related indoles
[patent_app_type] => utility
[patent_app_number] => 17/009586
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 44128
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17009586
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/009586 | Self-emulsifying formulations of DIM-related indoles | Aug 31, 2020 | Issued |
Array
(
[id] => 16513037
[patent_doc_number] => 20200392295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => THERAPEUTIC DENDRIMER
[patent_app_type] => utility
[patent_app_number] => 17/003699
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17003699
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/003699 | Therapeutic dendrimer | Aug 25, 2020 | Issued |
Array
(
[id] => 16761069
[patent_doc_number] => 20210106650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => MICROBICIDAL COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/942277
[patent_app_country] => US
[patent_app_date] => 2020-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16942277
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/942277 | MICROBICIDAL COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | Jul 28, 2020 | Abandoned |